Search Within

Mark E Robson

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (56)
  2. Meeting Abstract (51)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Breast Medicine Service (109)
  2. Department of Medicine (109)
  3. GSK Faculty (109)
  4. Human Oncology and Pathogenesis Program (109)
  5. Population Sciences Research Program (109)
  6. Solid Tumor Oncology Division (109)

More Groups

People
  1. Michael Berger (67)
  2. David Solit (56)
  3. Zsofia Stadler (56)
  4. Diana Mandelker (55)
  5. Kenneth Offit (55)
  6. Marc Ladanyi (51)

More People

Years
  1. 2024 (8)
  2. 2023 (8)
  3. 2022 (13)
  4. 2021 (9)
  5. 2020 (17)
  6. 2019 (16)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer Research (12)
  3. Clinical Cancer Research (5)
  4. JCO Precision Oncology (5)
  5. Journal of Thoracic Oncology (5)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (21)
  3. Nature Publishing Group (12)
  4. Elsevier Inc. (8)
  5. Oxford University Press (6)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (109)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ancestry-adjusted genomic analysis to identify known and novel associations with single and multiple cancer phenotypes
    Meeting Abstract

    Joseph, V.; Ravichandran, V.; Ostrovnaya, I.; Liu, Y. L.; Tkachuk, K.; Khurram, A.; Kemel, Y.; Mandelker, D.; Bandlamudi, C.; Walsh, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers
    Meeting Abstract

    Drago, J. Z.; Pareja, F.; Jhaveri, K. L.; Walsh, E. M.; Ku, G. Y.; Maron, S. B.; Janjigian, Y. Y.; Robson, M. E.; Reis-Filho, J. S.; Modi, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The histologic and genomic features of breast cancers harboring genetic alterations in RecQ DNA helicases
    Meeting Abstract

    Kaur, G.; Selenica, P.; Gazzo, A.; Cartagena, L. C.; Daaboul, F.; Dopeso, H.; da Silva, E. M.; Ross, D.; Zhang, H.; Wen, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
    Journal Article

    Belhadj, S.; Khurram, A.; Bandlamudi, C.; Palou-Márquez, G.; Ravichandran, V.; Steinsnyder, Z.; Wildman, T.; Catchings, A.; Kemel, Y.; Mukherjee, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
    Meeting Abstract

    Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save